The long time legal battle of Ripple vs SEC appears to have picked its momentum as the lawsuit is gaining some exciting movements. The lawsuit is currently in the summary judgment phase which has attracted various firms to be an Amicus Curiae.
Amicus Curiae is a process wherein the person or organization who acts as a friend to the court assisting the procedure will file the brief, here its in support of Ripple.
The latest updates claim that in Ripple vs the US Securities and Exchange Commission (SEC) legal tug of war, XRP Ledger (XRPL) backed company SpendTheBits Inc (STB) has filed to be XRP’s Amicus Curiae.
As per the reports, the SpendTheBits company has been making use of the open-source blockchain technology of XRP Ledger to battle against long delays and high cost Bitcoin transfers. As per amicus curiae document, just because the STB used Ripple’s technology, the application can now burn 0.00005 XRP in every transaction.
The document also briefs about STB’s launch in Canada where the firm asserts that the main reason for STB to opt Canada against the US is because of SEC’s stand in XRP lawsuit.
It was on October 28th that the US District Court Judge, Analisa Torres allowed Investor Choice Advocates Network and STB to file their amicus curiae briefs.
On the other hand, there are many firms who are standing as a support to Ripple against the SEC lawsuit. The Blockchain Association has claimed via twitter that they will be the recent ones to file for amicus curiae.
However, though there are requests from various companies to be an amicus curiae and even though most of them have already filed the briefs, the SEC has previously mentioned that its decision will not be dependent on any briefs.
A shift is underway at the SEC, as it is stepping away from surprise enforcement…
XRP had a wild ride this week, reaching a new all-time high of $3.65 before…
Back in 2021, few investors imagined that Shiba Inu (SHIB), a joke token with an…
The memecoin game is changing, and smart capital is flowing into tokens that deliver more…
MEI Pharma is making headlines with the announcement of a bold new Litecoin treasury strategy.…
Memecoins are roaring back as institutional interest, game-changing announcements, and bullish patterns drive the next…